Key statistics
On Friday, Bio-Techne Corp (TE1:BER) closed at 71.00, -7.79% below its 52-week high of 77.00, set on May 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 71.00 |
---|---|
High | 71.00 |
Low | 71.00 |
Bid | 70.00 |
Offer | 70.50 |
Previous close | 69.00 |
Average volume | 21.70 |
---|---|
Shares outstanding | 158.65m |
Free float | 157.02m |
P/E (TTM) | 74.82 |
Market cap | 12.42bn USD |
EPS (TTM) | 1.05 USD |
Annual div (ADY) | 0.2887 EUR |
---|---|
Annual div yield (ADY) | 0.41% |
Div ex-date | Aug 19 2024 |
Div pay-date | Aug 30 2024 |
Data delayed at least 15 minutes, as of Sep 20 2024 07:08 BST.
More ▼
Press releases
- BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT
- ScaleReady announces a G-Rex® Grant has been awarded to ImmunoScape
- ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics
- Verismo Therapeutics Awarded a ScaleReady™ G-Rex® Grant
- ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies
- ScaleReady announces the inaugural G-Rex® Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine
- BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
- BIO-TECHNE DECLARES DIVIDEND
- BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS
- BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM
More ▼